Primary Hyperparathyroidism: Outcomes of Repeated Imaging After Initial Negative Radiological Localization.
preoperative localization
primary hyperparathyroidism (phpt)
sestamibi scan
spect-ct
ultrasound
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
02
08
2023
medline:
4
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
Radiological localization imaging aids in the identification of abnormal parathyroid glands resulting in primary hyperparathyroidism (PHPT), thereby facilitating minimally invasive parathyroid surgery. Sometimes initial imaging may fail to identify the abnormal gland and imaging may therefore be repeated. This study explored patient outcomes of repeated parathyroid localization imaging, after initial negative gland localization, at a United Kingdom institution. Data was retrospectively collected and analyzed for patients with PHPT undergoing repeated imaging during a five-year period (2015-2020). The total number of episodes of scanning, types of scans performed, the time interval between scans and the imaging success of gland localization were recorded. We explored the reasons for repeated imaging and attempted to identify any factors that might predict subsequent positive radiological localization. A total of 45 patients were identified who underwent repeated localizing imaging after first localizing imaging was negative. Of these, 39 did not undergo surgery despite repeat imaging being undertaken; 11 out of these 39 patients (28%) had subsequent positive localization scans. Again, a large proportion of patients were managed conservatively, despite the repeated sets of imaging being done. Patients undergoing three or four sets of repetitive imaging did not have imaging or surgical success. A streamlined parathyroid pathway should be followed whereby patients should be triaged for suitability for surgery prior to repeated imaging. A second set of scans should be offered when patients are unsuitable for conservative management and are willing and fit to undergo surgery. There is no merit to repeating imaging more than twice.
Sections du résumé
BACKGROUND
BACKGROUND
Radiological localization imaging aids in the identification of abnormal parathyroid glands resulting in primary hyperparathyroidism (PHPT), thereby facilitating minimally invasive parathyroid surgery. Sometimes initial imaging may fail to identify the abnormal gland and imaging may therefore be repeated. This study explored patient outcomes of repeated parathyroid localization imaging, after initial negative gland localization, at a United Kingdom institution.
METHODOLOGY
METHODS
Data was retrospectively collected and analyzed for patients with PHPT undergoing repeated imaging during a five-year period (2015-2020). The total number of episodes of scanning, types of scans performed, the time interval between scans and the imaging success of gland localization were recorded. We explored the reasons for repeated imaging and attempted to identify any factors that might predict subsequent positive radiological localization.
RESULTS
RESULTS
A total of 45 patients were identified who underwent repeated localizing imaging after first localizing imaging was negative. Of these, 39 did not undergo surgery despite repeat imaging being undertaken; 11 out of these 39 patients (28%) had subsequent positive localization scans. Again, a large proportion of patients were managed conservatively, despite the repeated sets of imaging being done. Patients undergoing three or four sets of repetitive imaging did not have imaging or surgical success.
CONCLUSION
CONCLUSIONS
A streamlined parathyroid pathway should be followed whereby patients should be triaged for suitability for surgery prior to repeated imaging. A second set of scans should be offered when patients are unsuitable for conservative management and are willing and fit to undergo surgery. There is no merit to repeating imaging more than twice.
Identifiants
pubmed: 37664265
doi: 10.7759/cureus.42889
pmc: PMC10474611
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e42889Informations de copyright
Copyright © 2023, Karunaratne et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ann R Coll Surg Engl. 2019 Feb;101(2):97-102
pubmed: 30286659
World J Surg. 2020 Mar;44(3):803-809
pubmed: 31712842
Obes Res. 2001 Aug;9(8):470-7
pubmed: 11500527
Surg Oncol Clin N Am. 2016 Jan;25(1):103-18
pubmed: 26610777
Folia Med (Plovdiv). 2017 Dec 20;59(4):396-404
pubmed: 29341944
J Am Coll Surg. 2006 Jan;202(1):18-24
pubmed: 16377493
Surgery. 2008 Jul;144(1):74-9
pubmed: 18571587
Radiol Clin North Am. 2020 Nov;58(6):1071-1083
pubmed: 33040849
ANZ J Surg. 2018 Jan;88(1-2):E21-E24
pubmed: 27302092
Nat Rev Endocrinol. 2018 Feb;14(2):115-125
pubmed: 28885621
J Laryngol Otol. 2018 Mar;132(3):252-256
pubmed: 29512477
Eur J Endocrinol. 2000 Dec;143(6):755-60
pubmed: 11124858
Surgery. 2017 Jun;161(6):1651-1658
pubmed: 28108033
Sci Rep. 2019 Oct 10;9(1):14634
pubmed: 31602011
Radiol Clin North Am. 2011 May;49(3):489-509, vi
pubmed: 21569907
AJR Am J Roentgenol. 2018 May;210(5):1118-1122
pubmed: 29629803
Laryngoscope Investig Otolaryngol. 2018 Nov 28;4(1):188-192
pubmed: 30828638
Nucl Med Commun. 2003 Feb;24(2):121-4
pubmed: 12548035
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2801-2822
pubmed: 33839893